BlackRock Fund Advisors’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $820K | Sell |
157,987
-49,498
| -24% | -$257K | ﹤0.01% | 3236 |
|
|
2016
Q3 | $5.23M | Buy |
207,485
+10,270
| +5% | +$259K | ﹤0.01% | 2826 |
|
|
2016
Q2 | $4.88M | Buy |
197,215
+5,658
| +3% | +$140K | ﹤0.01% | 2824 |
|
|
2016
Q1 | $5.55M | Sell |
191,557
-1,233
| -0.6% | -$35.7K | ﹤0.01% | 2687 |
|
|
2015
Q4 | $7.16M | Buy |
192,790
+64,409
| +50% | +$2.39M | ﹤0.01% | 2641 |
|
|
2015
Q3 | $6.26M | Buy |
128,381
+11,258
| +10% | +$549K | ﹤0.01% | 2668 |
|
|
2015
Q2 | $8.08M | Buy |
117,123
+109,828
| +1,506% | +$7.57M | ﹤0.01% | 2631 |
|
|
2015
Q1 | $261K | Buy |
7,295
+3,242
| +80% | +$116K | ﹤0.01% | 3415 |
|
|
2014
Q4 | $51K | Buy |
4,053
+2,515
| +164% | +$31.6K | ﹤0.01% | 3672 |
|
|
2014
Q3 | $24K | Buy |
+1,538
| New | +$24K | ﹤0.01% | 3758 |
|